🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, randomized, open-label, Phase 3 study comparing the ...
Status
Completed
Location
Local Institution - 109
Start Date
2019-04-16
Trial ID
NCT03651128
The main purpose of this study is to collect additional safety information ...
Status
Completed
Location
Anhui Cancer Hospital
Start Date
2020-05-18
Trial ID
NCT04328662
The main aim is to show that long-term use of ixazomib can improve symptoms...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-06-30
Trial ID
NCT05183139
Treatments Being Tested
This study is the first study of tasquinimod, an inhibitor of S100A9, in pa...
Status
Terminated
Location
University of Pennsylvania
Start Date
2020-07-10
Trial ID
NCT04405167
Treatments Being Tested
The main aim is to evaluate the effect of Ixazomib in combination with lena...
Status
Terminated
Location
Arizona Oncology Associates
Start Date
2017-11-13
Trial ID
NCT03173092
Treatments Being Tested
This is a survey among pharmacists who have instructed NINLARO therapy in i...
Status
Completed
Location
Takeda selected site
Start Date
2023-06-01
Trial ID
NCT05882279
Treatments Being Tested
The clinical trial was conducted in a cohort of young, high-risk myeloma pa...
Status
Unknown
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Start Date
2018-01-05
Trial ID
NCT04008888